Language

News topic

Active ingredient SOLIFENACIN

Current shortage notices for the active ingredient SOLIFENACIN, structured by product, country and reporting period.

8 notices

← All shortages

What the SOLIFENACIN notices indicate for the supply chain

The 8 consolidated notices from Belgium, Czechia are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Solifenacin Krka 5 mg film-coat. tabl. 90

Active ingredient: Solifenacin

View notice details →
Belgium

Solifenacine Viatris 10 mg film-coat. tabl. 90

Active ingredient: Solifenacin

View notice details →
Belgium

Solifenacin Krka 10 mg film-coat. tabl. 250

Active ingredient: Solifenacin

View notice details →
Belgium

Solifenacin Krka 5 mg film-coat. tabl. 250

Active ingredient: Solifenacin

View notice details →
Belgium

Solifenacine/Tamsulosine AB 6 mg - 0.4 mg tabl. geregul. afgifte 30

Active ingredient: Solifenacin ; Tamsulosin

View notice details →